Ulf Meier-Kriesche
Direttore Tecnico/Scientifico/R&S presso VELOXIS PHARMACEUTICALS A/S
Profilo
Ulf Meier-Kriesche is currently the Chief Scientific Officer at Veloxis Pharmaceuticals A since 2017.
He obtained a doctorate degree from the University of Perugia.
Posizioni attive di Ulf Meier-Kriesche
Società | Posizione | Inizio |
---|---|---|
VELOXIS PHARMACEUTICALS A/S | Direttore Tecnico/Scientifico/R&S | 13/09/2017 |
Formazione di Ulf Meier-Kriesche
University of Perugia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Ulf Meier-Kriesche